U.S. Neurovascular Devices Market Size PPT

1
U.S. Neurovascular Devices Market Expected to
Reach 1,071 Million by 2027
www.alliedmarketresearch.com
2
Growth in prevalence of neurovascular diseases,
rise in geriatric population across the U.S.,
technological developments associated with
neurovascular devices, and increase in incidence
of underlying disease conditions drive the U.S.
Neurovascular Devices market. However, higher
prices of neurovascular devices hinder the market
growth. On the other hand, rise in demand for
minimally invasive procedures in U.S. presents
new opportunities in the coming years. Download
Sample Report (Detailed COVID-19 Impact)
at https//www.alliedmarketresearch.com/request-
sample/9050
www.alliedmarketresearch.com
3
The embolization devices segment to maintain its
lead position during the forecast period Based
on form, the embolization devices segment
accounted for more than two-fifths of the U.S.
neurovascular devices market in 2019, and is
estimated to maintain its lead position during
the forecast period. This is attributed to
increase in prevalence of neurovascular diseases,
introduction of technologically advanced
products, rise in RD investment, surge in
geriatric population, increase in adoption of
embolization devices, and surge in launch of new
and advanced neurovascular devices.  Click Here
_at_ https//www.alliedmarketresearch.com/press-relea
se/us-neurovascular-devices-market.html
www.alliedmarketresearch.com
4
The U.S. neurovascular devices market is
segmented on the basis of product and disease
pathology. Based on product, the market is
divided into embolization devices,
revascularization devices, thrombectomy devices,
embolic protection devices, and accessory
devices. The embolization devices segment
contributed to more than two-fifths of the U.S.
neurovascular devices market in 2019, and is
estimated to maintain its lead position during
the forecast period. On the other hand, the
revascularization devices segment is anticipated
to register the highest CAGR of 5.4 from 2020 to
2027. For Purchase Enquiry at
https//www.alliedmarketresearch.com/purchase-enqu
iry/9050
www.alliedmarketresearch.com
5

• Leading players
• B. Braun Melsungen AG
• Integer Holdings Corporation
• Johnson Johnson (Cerenovus)
• Medtronic Plc.
• Merit Medical Systems, Inc.
• Microport Scientific Corporation
• Penumbra, Inc.
• SAES Getters SpA (Memry Corporation)
• Stryker Corporation
• Terumo Corporation (Microvention, Inc.)

www.alliedmarketresearch.com
6
Contact Us David Correa5933 NE Win Sivers
Drive205, Portland, OR 97220United
StatesUSA/Canada (Toll Free)1-800-792-5285,
1-503-894-6022, 1-503-446-1141UK
44-845-528-1300Hong Kong 852-301-84916India (
Pune) 91-20-66346060help_at_alliedmarketresearch.c
om
www.alliedmarketresearch.com